Nitrofurantoin Oral Suspension 25Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Nitrofurantoin: Oral suspension (25mg)

Detailed Information
Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Visit Drug Summary Page
Drug Image file default-drug-image.png
Nitrofurantoin 25mg/5ml Susp
Drug Image file default-drug-image.png
Nitrofurantoin 25mg/5ml Susp
Drug Image file default-drug-image.png
Nitrofurantoin 25mg/5ml Susp
Drug Image file default-drug-image.png
Nitrofurantoin 25mg/5mL Susp

What is this Medicine?

NITROFURANTOIN (nye troe fyoor AN toyn) is an antibiotic. It is used to treat urinary tract infections.

Similar Brand Name Drugs : Furadantin: Oral suspension (25mg)
CVS Pharmacy Patient Statistics for Nitrofurantoin: Oral suspension(25mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Nitrofurantoin 25mg/5ml Suspension

NDC: 651620689
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Urinary Tract Infection (UTI) Prophylaxis, Cystitis, Urinary Tract Infection (UTI)

Storage Information
Protect from light
Protect from freezing
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Nitrofurantoin 25mg/5ml Suspension
Close All Sections Show

Reported Side Effects for Nitrofurantoin 25mg/5ml Suspension

Close Show
Stevens-Johnson Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Cholestasis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Psychosis Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Confusion Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Cyanosis Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Death Of Liver Tissue Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Pseudotumor Cerebri Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Exfoliative Dermatitis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Erythema Multiforme Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Depression Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Aplastic Anemia Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Pulmonary Fibrosis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Lung Inflammation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Inflamed Optic Nerve Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Low White Blood Cell Counts Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: DELAYED
No White Blood Cells Incidence:
1.0-5.0%*
Severity: SEVERE
Onset: DELAYED
Megaloblastic Anemia Incidence:
1.0-5.0%*
Severity: SEVERE
Onset: DELAYED
Hemolytic Anemia Incidence:
1.0-5.0%*
Severity: SEVERE
Onset: DELAYED
Low Platelet Count Incidence:
1.0-5.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
Close Show
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Nitrofurantoin

Close Show

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.